NCT01797029 A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh Status COMPLETED Phase PHASE3
NCT01793883 Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza Status COMPLETED Phase PHASE2
NCT01788514 Combining Entertainment & Influenza Education for Pediatric Patients Status COMPLETED Phase NA
NCT01788228 Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure Status COMPLETED Phase PHASE3
NCT01779570 Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections Status COMPLETED Phase PHASE4
NCT01774032 H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older Status COMPLETED Phase PHASE3
NCT01773928 Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived) Status COMPLETED Phase PHASE3
NCT01767896 Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine Status COMPLETED Phase PHASE3
NCT01759654 A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects Status COMPLETED Phase PHASE3
NCT01756950 Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses Status COMPLETED Phase PHASE1
NCT01755364 A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old Status COMPLETED Phase PHASE3
NCT01752881 Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects Status COMPLETED Phase PHASE4
NCT01746082 Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations Status COMPLETED Phase PHASE2
NCT01740063 Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza Status COMPLETED Phase PHASE2
NCT01736709 The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine Status COMPLETED Phase PHASE4